BALF TNFα level in relation to inflammatory status and phenotype of sarcoidosis

A. Goljan Geremek, M. Bednarek, E. Puscinska, M. Czystowska, M. Franczuk, I. Bestry, M. Filewska, M. Kram, U. Demkow, D. Górecka (Warsaw, Poland)

Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Session: Cystic lung diseases: lung granulomatosis
Session type: Thematic Poster Session
Number: 698

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Goljan Geremek, M. Bednarek, E. Puscinska, M. Czystowska, M. Franczuk, I. Bestry, M. Filewska, M. Kram, U. Demkow, D. Górecka (Warsaw, Poland). BALF TNFα level in relation to inflammatory status and phenotype of sarcoidosis. Eur Respir J 2012; 40: Suppl. 56, 698

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between macrophage inflammatory protein-3β(MIP-3β) levels and clinical course of sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 173s
Year: 2002

Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


The relationship between the course of sarcoidosis and changes of markers of the disease activity in a bronchoalveolar lavage fluid
Source: Eur Respir J 2002; 20: Suppl. 38, 469s
Year: 2002

Clinical significance of different cytokines expression in lung tissue in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002

Determination of IL-8 concentration and the activity of β-glucuronidase in BAL samples in children with inflammatory lung disease
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010


Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 377s
Year: 2003

Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
Source: Eur Respir J 2003; 21: 407-413
Year: 2003



Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Relationship between radiologic patterns, pulmonary function values and BALF cells in newly diagnosed sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


Pathogenetic pathways in pulmonary fibrosis: The role of bronchoalveolar lavage (BAL) cellularity in relation to epithelial injury
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


Microparticles-associated tissue factor activity is increased in bronchoalveolar lavage of patients with pulmonary fibrosis and correlates with functional impairment
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Role of BALF in differential diagnosis of smoking related interstitial lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?
Source: Eur Respir J 2002; 20: Suppl. 38, 468s
Year: 2002

Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?
Source: Eur Respir J 2001; 18: Suppl. 33, 507s
Year: 2001

Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017